Ignite Creation Date:
2025-12-25 @ 2:10 AM
Ignite Modification Date:
2026-01-08 @ 9:19 AM
Study NCT ID:
NCT06384560
Status:
RECRUITING
Last Update Posted:
2025-01-20
First Post:
2024-04-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Neoadjuvant Triple Treatment for Borderline Resectable Pancreatic Cancer (PREOPANC-5)
Sponsor:
Amsterdam UMC, location VUmc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-09-23
Start Date Type:
ACTUAL
Primary Completion Date:
2028-03
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-03
Completion Date Type:
ESTIMATED
First Submit Date:
2024-04-16
First Submit QC Date:
None
Study First Post Date:
2024-04-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-01-16
Last Update Post Date:
2025-01-20
Last Update Post Date Type:
ACTUAL